Sundance Biosciences patents new TYK2 inhibitors for multiple sclerosis
Sundance Biosciences patents new TYK2 inhibitors for multiple sclerosis
Sundance Biosciences patents new TYK2 inhibitors for multiple sclerosis
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page